May 20-22
Boston, MA, USA

David Schubert

David Schubert

Company: Roche

Job title: Principal Scientist

Seminars:

A Novel IgG-IL2 Mutein to Selectively Activate T Regulatory Cells 2:45 pm

• Design and development of an IL-2 mutein showing Treg specificity • Assessment of Treg pharmacology in vitro and in vivo in non-clinical studies • Path towards clinical development of Treg therapies using IL-2 muteinsRead more

day: Day One

OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com

VENUE DETAILS

The Revere Boston Common Hotel
200 Stuart St,
Boston, MA
02116, USA

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

SEARCH

ORGANISED BY

Terms & Conditions

Privacy Policy

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.